Journal of Biopharmaceutical Statistics

Title Publication Date Language Citations
Diagnostic Thresholds with Three Ordinal Groups2014/04/15English18
Reliably Basing Conclusions on Subgroups of Randomized Clinical Trials2014/01/02English18
Standardization for Subgroup Analysis in Randomized Controlled Trials2014/01/02English18
Decision Making from Phase II to Phase III and the Probability of Success: Reassured by “Assurance”?2013/08/19English18
Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: noncompliance and missing data2018/07/11English18
Comparison of Single-Arm vs. Randomized Phase II Clinical Trials: A Bayesian Approach2014/06/04English18
Bioequivalence and intrasubject variability1991/01/01English18
The assessment of individual and population bioequivalence1996/01/01English18
Dose Finding Designs for Continuous Responses and Binary Utility2007/11/08English18
Overview of Vaccine Field Studies: Types of Effects and Designs2006/08/01English18
Current Issues in Oncology Drug Development, with a Focus on Phase II Trials2009/04/21English18
Multiregional Clinical Trials: Japanese Perspective on Drug Development Strategy and Sample Size for Japanese Subjects2012/09/01English18
Bayesian Joint Modeling of Longitudinal Measurements and Time-to-Event Data Using Robust Distributions2014/05/14English18
Evaluating efficiency and statistical power of self-controlled case series and self-controlled risk interval designs in vaccine safety2016/01/08English18
Predicting Event Times in Clinical Trials When Treatment Arm Is Masked2006/07/01English17
The multivariate assessment of bioequivalence1997/01/01English17
Optimum Design of Experiments for Enzyme Inhibition Kinetic Models2011/03/24English17
Partial Youden index and its inferences2018/10/25English17
Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strata2020/03/04English17
Using Tolerance Intervals for Assessment of Pharmaceutical Quality2014/10/30English17
Statistical Consideration and Challenges in Bridging Study of Personalized Medicine2014/06/04English17
Drug Dosage Individualization Based on a Random-Effects Linear Model2012/03/14English17
A Bayesian Inference of P(π1 > π2) for Two Proportions2012/03/14English17
Assessment of Regional Treatment Effect in a Multiregional Clinical Trial2012/09/01English17
Multistage and Mixture Parallel Gatekeeping Procedures in Clinical Trials2011/04/22English17
Bayesian Average Error-Based Approach to Sample Size Calculations for Hypothesis Testing2013/04/23English17
Statistical comparison of stability study designs1992/01/01English17
Regression Models for Method Comparison Data2007/07/02English17
Adaptive Designs in Clinical Drug Development: Opportunities, Challenges, and Scope Reflections Following PhRMA's November 2006 Workshop2007/11/08English17
Evaluation of inferential methods for the net benefit and win ratio statistics2020/02/25English17